TORONTO, Nov. 25, 2013 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company") is pleased to announce the following:
Biosign Schedules Investor Conference Call
Biosign is pleased to announce an Investor Conference Call, scheduled for Wednesday, November 27(th) , 2013 at 11:00 AM Eastern Daylight Time. During this call, Biosign CEO Robert Kaul will read a prepared statement commenting on recent news releases and providing additional discussion on the Company's business plan. Following this presentation, Mr. Kaul will answer a number of questions previously submitted from participants regarding the business of the Company.
The conference call is open to any investor or stakeholder, including shareholders, broker-dealers and other securities professionals. The call will be recorded and available for review at https://biosign.com/investors. To submit one or more questions to the CEO, please email your question to ceo@biosign.com with the words "Investor Question for Conference Call" in the subject line. Biosign management will endeavour to address as many questions as possible in the one-hour time period allocated to the call. To participate in the call, please use the following login credentials:
Dial-In Number: 877-394-5901
Participant Code: 2169148
Date: November 27(th) , 2013 at 11:00 AM EDT
Biosign CEO Robert Kaul stated, "Throughout November, Biosign has made a number of material announcements related to our business plan. Management is pleased to be able to communicate with investors and other interested parties in order to place these announcements into greater context, and to address various stakeholder inquiries."